Rigel Pharmaceuticals | RIGL - PE Price to Earnings


Rigel Pharmaceuticals reported 8.61 in PE Price to Earnings for its fiscal quarter ending in March of 2025.





Pe Change Date
Amgen 25.31 15.82 Dec/2025
Anika Therapeutics 47.54 27.2 Jun/2024
AstraZeneca 27.29 5.8 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Daiichi Sankyo 20.73 1.74 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Halozyme Therapeutics 23.16 7.7 Dec/2025
Intrexon 7.54 221.44 Dec/2021
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ligand Pharmaceuticals 60.65 17.62 Sep/2025
Neurocrine Biosciences 835.47 802.2 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Veracyte 45.3 5.4 Dec/2025